Hon‐Wah Man

2.0k total citations
24 papers, 1.5k citations indexed

About

Hon‐Wah Man is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Hon‐Wah Man has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Organic Chemistry and 7 papers in Hematology. Recurrent topics in Hon‐Wah Man's work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Hon‐Wah Man is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Hon‐Wah Man collaborates with scholars based in United States, Switzerland and United Kingdom. Hon‐Wah Man's co-authors include George W. Muller, Peter Schäfer, David Stirling, Donald S. Matteson, Prabhakar K. Jadhav, Laura G. Corral, Anastasia Parton, Faribourz Payvandi, Roger S. Chen and Lori Capone and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hon‐Wah Man

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hon‐Wah Man United States 17 784 459 412 277 247 24 1.5k
Bi‐Ching Sang United States 18 1.2k 1.6× 232 0.5× 337 0.8× 711 2.6× 246 1.0× 30 2.2k
Hiroshi Kosugi Japan 27 743 0.9× 313 0.7× 799 1.9× 429 1.5× 167 0.7× 112 2.3k
Lang Ngo United States 17 2.2k 2.8× 163 0.4× 179 0.4× 705 2.5× 127 0.5× 19 2.5k
Lu Min Wong United States 15 477 0.6× 234 0.5× 229 0.6× 276 1.0× 183 0.7× 21 1.0k
Michael Furlong United States 20 562 0.7× 145 0.3× 181 0.4× 174 0.6× 733 3.0× 31 1.8k
Paul Nimmer United States 8 1.8k 2.3× 344 0.7× 222 0.5× 665 2.4× 315 1.3× 11 2.4k
Philip R. Hamann United States 20 673 0.9× 210 0.5× 356 0.9× 930 3.4× 241 1.0× 28 2.0k
Guido Bold Switzerland 25 907 1.2× 131 0.3× 758 1.8× 490 1.8× 74 0.3× 46 1.8k
Edvardas Kaminskas United States 20 1.2k 1.6× 513 1.1× 78 0.2× 405 1.5× 138 0.6× 33 2.1k
Neil Moss United States 19 1.1k 1.4× 112 0.2× 623 1.5× 362 1.3× 110 0.4× 34 1.7k

Countries citing papers authored by Hon‐Wah Man

Since Specialization
Citations

This map shows the geographic impact of Hon‐Wah Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hon‐Wah Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hon‐Wah Man more than expected).

Fields of papers citing papers by Hon‐Wah Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hon‐Wah Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hon‐Wah Man. The network helps show where Hon‐Wah Man may publish in the future.

Co-authorship network of co-authors of Hon‐Wah Man

This figure shows the co-authorship network connecting the top 25 collaborators of Hon‐Wah Man. A scholar is included among the top collaborators of Hon‐Wah Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hon‐Wah Man. Hon‐Wah Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Qi, et al.. (2025). Copper-Catalyzed Selective N-Sulfenylation of Tryptophan-Containing Peptides. Organic Letters. 27(50). 14107–14111.
2.
Chu, Qiao, Xuehui Chu, Yajing Yang, et al.. (2025). S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathway. Cellular Oncology. 48(5). 1433–1447. 1 indexed citations
3.
Matyskiela, Mary E., Weihong Zhang, Hon‐Wah Man, et al.. (2017). A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos. Journal of Medicinal Chemistry. 61(2). 535–542. 203 indexed citations
4.
Schäfer, Peter, Anastasia Parton, Lori Capone, et al.. (2014). Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cellular Signalling. 26(9). 2016–2029. 248 indexed citations
5.
Ruchelman, Alexander L., Hon‐Wah Man, Weihong Zhang, et al.. (2012). Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters. 23(1). 360–365. 50 indexed citations
6.
Ruchelman, Alexander L., Hon‐Wah Man, Roger Chen, et al.. (2011). 1,1-Diarylalkenes as anticancer agents: Dual inhibitors of tubulin polymerization and phosphodiesterase 4. Bioorganic & Medicinal Chemistry. 19(21). 6356–6374. 22 indexed citations
7.
Lu, Ling, Faribourz Payvandi, Lei Wu, et al.. (2008). The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions. Microvascular Research. 77(2). 78–86. 183 indexed citations
8.
Colston, Kay W., et al.. (2008). Antiproliferative Effects of CC-8062 and CC-8075 in Pancreatic Cancer Cells. Pancreas. 38(1). 78–84. 13 indexed citations
9.
Marriott, J B, Ian Clarke, Anna Czajka, et al.. (2003). A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.. PubMed. 63(3). 593–9. 45 indexed citations
10.
Man, Hon‐Wah, Laura G. Corral, David Stirling, & George W. Muller. (2003). α-Fluoro-substituted thalidomide analogues. Bioorganic & Medicinal Chemistry Letters. 13(20). 3415–3417. 38 indexed citations
11.
Schäfer, Peter, Anita K. Gandhi, Roger S. Chen, et al.. (2003). Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1222–1232. 155 indexed citations
12.
Chung, Francisco, Brian D. Palmer, George W. Muller, et al.. (2003). Effect of 3-Fluorothalidomide and 3-Methylthalidomide Enantiomers on Tumor Necrosis Factor Production and Antitumor Responses to the Antivascular Agent 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA). Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 14(2). 75–82. 13 indexed citations
13.
Prehn, John, et al.. (2001). Potent Inhibition of Cytokine Production from Intestinal Lamina Propria T Cells by Phosphodiesterase-4 Inhibitory Thalidomide Analogues. Journal of Clinical Immunology. 21(5). 357–364. 10 indexed citations
14.
Man, Hon‐Wah, William C. Hiscox, & Donald S. Matteson. (1999). A Highly Enantioselective and Diastereoselective Synthesis of Cyclobutanes via Boronic Esters. Organic Letters. 1(3). 379–382. 24 indexed citations
15.
Jadhav, Prabhakar K. & Hon‐Wah Man. (1997). Enantiotopic Differentiation of pro-R or pro-S Chlorides in (Dichloromethyl)borates by Chiral Lewis Acids:  Enantioselective Synthesis of (α-Chloroalkyl)boronates. Journal of the American Chemical Society. 119(4). 846–847. 29 indexed citations
16.
Jadhav, Prabhakar K., Francis J. Woerner, & Hon‐Wah Man. (1997). Synthesis of 7-membered cyclic hydroxyguanidines: Novel HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 7(17). 2145–2148. 4 indexed citations
17.
Jadhav, Prabhakar K. & Hon‐Wah Man. (1996). Direct Synthesis of [α-[(tert-Butoxycarbonyl)amino]alkyl]- boronates from (α-Haloalkyl)boronates. The Journal of Organic Chemistry. 61(22). 7951–7954. 12 indexed citations
18.
Jadhav, Prabhakar K. & Hon‐Wah Man. (1996). Synthesis of 7-membered cyclic oxamides: Novel HIV-1 protease inhibitors. Tetrahedron Letters. 37(8). 1153–1156. 28 indexed citations
19.
Matteson, Donald S. & Hon‐Wah Man. (1996). Hydrolysis of Substituted 1,3,2-Dioxaborolanes and an Asymmetric Synthesis of a Differentially Protected syn,syn-3-Methyl-2,4-hexanediol. The Journal of Organic Chemistry. 61(17). 6047–6051. 43 indexed citations
20.
Matteson, Donald S., et al.. (1996). Asymmetric Synthesis of Stegobinone via Boronic Ester Chemistry. Journal of the American Chemical Society. 118(19). 4560–4566. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bi‐Ching Sang Breakdown of academic impact, for papers by Hiroshi Kosugi Breakdown of academic impact, for papers by Lang Ngo Breakdown of academic impact, for papers by Lu Min Wong Breakdown of academic impact, for papers by Michael Furlong Breakdown of academic impact, for papers by Paul Nimmer Breakdown of academic impact, for papers by Philip R. Hamann Breakdown of academic impact, for papers by Guido Bold Breakdown of academic impact, for papers by Edvardas Kaminskas Breakdown of academic impact, for papers by Neil Moss
Rankless by CCL
2026